AI assistant
Sending…
BridgeBio Pharma, Inc. — Director's Dealing 2024
Aug 21, 2024
30604_dirs_2024-08-20_5e013626-99ae-4726-abca-a8aa99eac30b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BridgeBio Pharma, Inc. (BBIO)
CIK: 0001743881
Period of Report: 2024-08-16
Reporting Person: Trimarchi Thomas (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-16 | Common Stock | F | 17936 | $24.40 | Disposed | 395923 | Direct |
Footnotes
F1: Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 32,431 shares of Common Stock underlying the Reporting Person's restricted stock units.
More from BridgeBio Pharma, Inc.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 8
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 27